First-line continuous or intermittent capecitabine vs cyclophosphamide + methotrexate + fluorouracil in women with advanced breast cancer who were unsuitable for more intensive treatment
Phase of Trial: Phase III
Latest Information Update: 21 Dec 2011
At a glance
- Drugs Capecitabine; Cyclophosphamide; Fluorouracil; Methotrexate
- Indications Advanced breast cancer
- Focus Therapeutic Use
- 24 Oct 2011 Results published in the Journal of Clinical Oncology.
- 27 Mar 2010 Results from an analysis of three trials presented at the 7th European Breast Cancer Conference
- 13 Aug 2007 New trial record.